Technology News and Research

RSS

Regulus Therapeutics' metabolic disease program data presented at Diabetes Keystone Symposium

Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the "Diabetes" Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having no significant effect on glucose or insulin levels in normal mice.

16 Apr 2010

3M Drug Delivery Systems grows its product portfolio in Asia’s pharmaceutical industry

3M Drug Delivery Systems recently advanced its participation in the Asian market with a sponsorship of the Asia Pharma R&D Leaders 2010 event, held March 4 and 5 in Shanghai, China.

16 Apr 2010

Federal Research Public Access Act introduced in House of Representatives

Fueling the growing momentum toward openness, transparency, and accessibility to publicly funded information, the Federal Research Public Access Act of 2010 (FRPAA) has been introduced today in the U.S. House of Representatives by Rep. Mike Doyle (D-PA) and a bi-partisan host of co-sponsors.

16 Apr 2010

Community colleges to have new curriculum to educate HIT workers

Community colleges will soon have the capacity and ability to educate much-needed health information technology workers. Using a new six to 12 month informatics curriculum developed at the Johns Hopkins University School of Nursing and deployed throughout the U.S., local colleges will have access to high-quality HIT educational programs, while helping their instructors supplement their own level of knowledge.

16 Apr 2010

Genocea Biosciences, NMRC sign CRADA to develop vaccine against malaria

Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has entered into a Cooperative Research and Development Agreement with the Naval Medical Research Center. NMRC will collaborate with Genocea to identify antigens that will be used in the development of a vaccine candidate against Plasmodium falciparum for the prevention of malaria.

16 Apr 2010

Sorrento Therapeutics completes construction of fully human mAbs library

Sorrento Therapeutics, Inc. today announced that it has completed the construction of an extensive library of full-length, fully human monoclonal antibodies (mAbs). Initial analysis indicates a potential diversity of more than one trillion unique mAbs. The company believes this makes its library the largest full-length, fully human antibody library available for drug discovery and development partnerships.

15 Apr 2010

Smith & Nephew to launch new line extensions to ACTICOAT antimicrobial barrier dressing portfolio

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.

15 Apr 2010

Texas Health, LHP form joint venture to acquire Wilson N. Jones Medical Center

Texas Health Resources, the largest health care system in North Texas in terms of patients served, and LHP Hospital Group, Inc., have formed a joint venture to acquire Wilson N. Jones Medical Center in Sherman, Texas. Texas Health will own a majority equity interest in the joint venture that owns Texas Health Presbyterian Hospital-WNJ and LHP will manage the operation of the hospital.

15 Apr 2010

Early, accurate detection of superficial bladder cancer with Olympus PDD

With Olympus photodynamic diagnosis (PDD), superficial bladder cancer can be detected earlier, easier and more accurately. Bladder cancer is diagnosed by cystoscopy, the endoscopic introduction of a light source through the urethra (transurethral) into the bladder. The imaging technology PDD uses blue light to increase the contrast between tumour tissue (red) and healthy tissue (blue).

From Evident Corporation - Life Sciences 15 Apr 2010

Foundation Medicine completes $25M Series A financing led by Third Rock Ventures

Foundation Medicine, a personalized cancer medicine company that aims to bring comprehensive cancer genome analysis into routine clinical care, today announced it has completed a $25 million Series A financing led by Third Rock Ventures.

15 Apr 2010

ETC's BioMedical Division to introduce new BARA-MED Select monoplace hyperbaric chamber

Environmental Tectonics Corporation today announced that its BioMedical Division will be exhibiting their new BARA-MED Select monoplace hyperbaric chamber. This new chamber, which is an addition to ETC's monoplace line, includes an undercarriage gurney storage for optimized space usage and features a fourth-generation, automated computerized operating system for control and recordkeeping, a passive pressure relief mattress, SMOOTH-RIDE™, and an adjustable height gurney and computerized treatment protocols.

15 Apr 2010

The Forum 2010 to focus primarily on HIT

In response to the millions of federal dollars available to healthcare providers who install electronic patient records systems in their facilities, the Colorado Rural Health Center (CRHC) and ClinicNET's "The Forum 2010" will focus primarily on Health Information Technology (HIT). The event, held in Aurora, CO, runs from April 19-21.

15 Apr 2010

GE and U.S. Army to evaluate deployed soldiers for TBI and PTSD symptoms

As part of GE's continuing efforts to support U.S. troops, GE Global Research, the technology development arm of the General Electric Company, is engaged in a two-year research study with the U.S. Army to evaluate soldiers returning from Iraq and Afghanistan for traumatic brain injuries (TBI) and post-traumatic stress disorders (PTSD).

15 Apr 2010

Phase Forward's European Users Conference to be held in Budapest, Hungary

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, will host its eighth annual European Users Conference (EUC) April 21 - 22 at the Corinthia Hotel in Budapest, Hungary.

15 Apr 2010

Artificial pancreas system succeeds in maintaining near-normal glucose levels

An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin and the blood-sugar-raising hormone glucagon, was developed at Boston University.

15 Apr 2010

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled "Stent with Helical Elements." The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.

15 Apr 2010

New cardiac CT technology promises low radiation exposure and improved image quality

Cardiovascular disease is the leading cause of death globally and a tremendous burden on the healthcare system. Better detection of hardening or clogging of arteries and other blood vessels before symptoms occur is needed.

15 Apr 2010

Campaign for Better Care focuses on older adults with multiple health problems

"Will you help her?" That's the question the Campaign for Better Care, led by the National Partnership for Women & Families, Community Catalyst and the National Health Law Program, is asking policymakers today in new print and banner ads running in The Hill, Politico and Roll Call.

15 Apr 2010

Newsweek examines tech startup's tools to fight malaria

Newsweek examines the work of Intellectual Ventures, a Seattle-based startup that is "trying to develop a computer model that could help eradicate malaria."

15 Apr 2010

Successful stem cell therapy performed on CHF patients in Mexico

Bioheart, Inc. announced that treatment with stem cell therapy on two congestive heart failure (CHF) patients was performed successfully at the Hospital Angeles Tijuana, Mexico, through Bioheart's Center of Excellence program with Regenerative Medicine Institute.

15 Apr 2010